Gynecomastia And Hormonal Imbalances

By , in Gynecomastia.

Gynecomastia And Hormonal Imbalances

Many will argue that there is lots to yet be learned and discovered about gynecomastia. For others the real answers, keys and solutions lie in understanding the body and why these telltale manifestations (outwardly, physical, gender-area specific, endocrine?) are occurring.

If we unlock the secrets, functions, interconnectedness and dynamics of the hormones, level, natural processes, balance in the body, we will be that much closer in decoding and understanding, as well as treating gynecomastia effectively.

An imbalance in the body due to estrogen/testosterone (female and male hormones) are at the very core of this condition and disorder, anomaly and illness.  Disturbances, disruption and imbalances in these hormonal, endocrine-type levels  as well as the androgen action at the breast tissue level is thought to lie at the heart of cause and results in gynecomastia.

Enhancement of aromatization of androgens to estrogens is important in the pathogenesis of gynecomastia. This is medically sactioned input for dealing with underlying causality and contributory factors to gynecomastia.

According to medical knowledge and research, current on-going studies, patient input, gynecomastia can sometimes be associated with obesity (mostly not),  can occur as a natural part of aging, puberty. It can also be attributed to chronic illness and underlying disease, like kidney and liver disease, thyrotoxicosis, 17-oxosteroid reductase deficiency. Klinefelter’s syndrome, and neoplasms of the testes, adrenals and liver problems.

It is sometimes referred to as a primary aromatase excess syndrome with exuberant gynecomastia (enlargements of the breasts (female breast tissue and function) on a man/male.

Occurrence can be random, with complex causality, sporadically or even familiar/geneticaly predispositions are also documented and common.

Some of the medications that have proven effective to deal with these fluctuation hormonal issues in gynecomastia, is delta1-testolactone, which reduces the size of the breast glandular tissue. Althought these types of medications do not necessarily totally get rid of the enlarged, female-type breasts on men, it does not get rid of the problem in its totality.

Newer generation of more potent aromatase inhibitors are making and finding their way onto the market as we begin to understand gynecomastia a little better.